ENTITY

Insmed Inc (INSM US)

8
Analysis
Health Care • United States
Insmed, Inc. is a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies for patients with high unmet need battling serious orphan lung diseases.
more
bullish•Seagate
•11 Dec 2025 09:12

Nasdaq100 December 2025 Forecast (Final): 12 Changes

​STX, ALNY, WDC are the top forecasted addition. TTD, ON, LULU are the top forecasted deletions. FER can be a surprise addition displacing EBAY.

Logo
1.5k Views
Share
•20 Aug 2025 04:20

Staying Bullish Despite Near-Term Pullback Potential; Buy Pullbacks

Buying a pullback; SPX testing 6400-6410 now, but QQQ and IWM are violating short-term supports at $572 and $226. This makes us believe we could...

Logo
348 Views
Share
bullish•S&P 500 INDEX
•10 Aug 2022 06:18

S&P 500, Nasdaq 100 Testing Key Resistance Levels; Pause Likely; Buying Biotech

$SPX is testing important resistance in the 4165-4180 area, the same resistance level we were monitoring in early June before the market tumbled 13...

Logo
449 Views
Share
bullish•S&P 500 INDEX
•10 Feb 2021 10:34

U.S. Equity Strategy: Bullish Outlook Intact

The action we are seeing in broad indexes, Sectors, and in market dynamics continues to support our overall bullish outlook. Continue to buy dips.

Logo
306 Views
Share
bearish•Wirecard AG
•22 Jun 2020 05:30

Wirecard – Yolk’s On Everyone

*Another Potential Fraud: Shares of Wirecard (WDI.GR) fell by as much as 67% after the German payments and card-issuing firm disclosed that Ernst...

Share
x